Bristol Myers Squibb Boosts Its Neuroscience Reach With $14 Billion Karuna Deal

← Back to stories
National7 articles from 7 sources across the spectrum· Updated 1013d ago

6 across the spectrum · tap a section to jump

How each side is putting it

Left

2 viewpoints
New York TimesLean Left· 1013d ago

Bristol Myers to Acquire Karuna, a Neuroscience Drugmaker, for $14 Billion

Kilgore News HeraldLean Left· 1013d ago

Karuna Therapeutics soars after $14 billion takeover by Bristol Myers

Center

3 viewpoints
Ran by 2 outlets· NBC10 Philadelphia, NBC New York
NBC10 PhiladelphiaLean Left· 1013d ago

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

NBC New YorkLean Left· 1013d ago

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

InvestopediaCenter· 1013d ago

Bristol Myers Squibb Boosts Its Neuroscience Reach With $14 Billion Karuna Deal

Wall Street JournalCenter· 1013d ago

WSJ News Exclusive | Bristol Myers to Buy Karuna Therapeutics for $14 Billion

Right

1 viewpoint
FOX BusinessLean Right· 1013d ago

Bristol Myers to buy Karuna Therapeutics for $14B

Bristol Myers Squibb Boosts Its Neuroscience Reach With $14 Billion Karuna Deal | Slantwise